goodthingsforlifelogo.jpg          Good Things For Life Wellness Center


Use of state-of-the-art molecular biology techniques (micro-array, PCR, RT-PCR, southern and less northern blot, etc.). Previous technology used clonogenic, ATP-TCA, MTT, and SRB assays which are accurate, more restrictive in their results and less efficient.

Investigate genes that are necessary for the growth and survival of the tumor.

Investigate the mechanisms by which the cancer cells resists chemotherapeutic drugs (MDR1 protein,  LRP protein, glutathione transferase, gene amplification, etc.).

Test for mechanisms of neovascularization and infiltration of the tumor, which is necessary for tumor metastasis.

Tests for about 50+ nutrients which can cause  apoptosis of the cancer cells, act as anti-angiogenesis factors, anti-tumor growth factors, help decrease expression of MDR1, help regulate P27 and P53 pathways, and stimulate tremendous immune responses etc.  Also testing all the chemo drugsnot just those approved by the FDA for your type of cancer, thereby creating a truly individual treatment program.

Specifically test by micro-array technique the heat shock proteins (HSP) that shows if the cancer cells are sensitive to hyperthermia treatments and/or radiotherapy.

The entire test from time of shipping to the point of receiving results is 7 to 10 working days.  Previous techniques need 30-40+ days to receive results.

Both scientifically and clinically there are considerably less false positive and negative results than seen in previous techniques.

Previous techniques used cell cultures and test cell lines from tissue samples only.  The cell line is only one subclone from the total metastatic cancer cell population.  Therefore, the analysis provides information only for this subclone. In micro-array the analysis involves testing of all the metastaticsubclones from the tumor.

Previous techniques could only use tissue samples which are not always available, especially in advanced stages of disease.  Micro-array can be made by isolation of circulating cancer cells found in peripheral blood. This allows clinicians to perform this test by blood draw in the office not just with biopsy.

To learn more about the Greece cancer test go to